FDA grants priority review to Vivitrol for opioid dependence - ONA

Links shared publicly online about this topic.

  • 1,142
    total visits

FDA grants priority review to Vivitrol for opioid dependence - ONA

oncologynurseadvisor.com

Alkermes announced that the supplemental New Drug Application (sNDA) for Vivitrol (naltrexone for extended-release injectable suspension) for opioid dependence has been granted priority review by the FDA.

View full resource at oncologynurseadvisor.com

Tags: Drug, FDA

  • Share

Most Recently Shared on May 25, 2010 at 8:42 pm By:

ONAcom OncologyNurseAdvisor

FDA grants priority review to Vivitrol for opioid dependence http://goo.gl/fb/icIQU

2 years ago...

Alkermes Announces Priority Review By FDA For VIVITROL(R) For Opioid Dependence

medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) announced that the supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence has been dView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 27, 2010 at 2:10 pm By:

mnt_alcoholadd MNT Alcohol / Addict Health News

Alkermes Announces Priority Review By FDA For VIVITROL(R) For Opioid Dependence http://mnt.to/3D8x #alcohol #addiction

2 years ago...

FDA grants priority review to Vivitrol for opioid dependence - MPR

empr.com — “Alkermes announced that the supplemental New Drug Application (sNDA) for Vivitrol (naltrexone for extended-release injectable suspension) for opioid dependence has been granted priority review by the FDA.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 25, 2010 at 4:44 pm By:

eMPR MPR Medical Publisher

FDA grants priority review to Vivitrol for opioid dependence: Alkermes announced that the supplemental New Drug Ap... http://bit.ly/bdN3HW

2 years ago...

Advertisement